Medtronic to Acquire Medicrea for Boosting its Spine Offerings

 Medtronic to Acquire Medicrea for Boosting its Spine Offerings

Shots:

  • Medtronic to acquire all outstanding shares of Medicrea along with its MEDICREA UNiD ASI for about $7.98/ share with a premium of 22% over the closing price of shares on Jul 14, 2020. The acquisition is expected to be closed at the end of 2020
  • Medtronic has commitments to buy 44.4% of Medicrea’s current outstanding share capital. The acquisition enables Medtronic to become the first company to offer AI-driven surgical planning, personalized spinal implants, and robotic-assisted surgical delivery
  • Assimilation of Medicrea’s capabilities and solutions in data analytics, AI and personalized implants with Medtronic’s portfolio of spine implants, robotics, navigation, and 3D imaging technology improves Medtronic’s procedural solution for surgical planning and delivery

Click here to read full press release/ article | Ref: Businesswire | Image: OrthoSpineNews

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post